Figure 1.
SNHG12 expression was upregulated in DLBCL tissues and correlated with clinical prognosis. (A) Relative expression of SNHG12 was verified in DLBCL (n = 80) tissues compared to control lymphoid hyperplasia tissues (n = 80) by quantitative real-time PCR. (B) Relative expression of SNHG12 was verified in DLBCL cell lines. The overall survival (C) and disease-free survival (D) of patients with low and high expression of SNHG12 (SNHG12 high, n = 40; SNHG12 low, n = 40). Data are presented as mean ± SD of three independent experiments. ***P < 0.001.
Abbreviation: DLBCL, diffuse large B-cell lymphoma.